OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ACME55

Acme Pesticides Ltd

Agricultural ChemicalsVerified

Acme Pesticides Ltd has a fully diluted share count of 135 million, with no difference between basic and diluted shares, indicating no dilution risk from stock options or convertible instruments. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available for comparison against industry medians, as no financial data is provided in the valuation snapshot. In the Agricultural Chemicals industry, key metrics such as EBITDA margins, ROIC, and net profit margins are typically used to assess performance. Without these, a direct comparison to industry benchmarks is not possible. The company's revenue concentration by segment and geography is not disclosed in the available data. In the absence of segmental or geographic breakdowns, it is unclear whether Acme Pesticides Ltd is exposed to regional or product-specific concentration risks. Disclosed segments would typically include crop protection, industrial chemicals, or specialty products, but none are available for analysis. Growth trajectory data is also unavailable, as no revenue history or outlook figures are provided. The outlook section does not include current or next fiscal year direction or numeric deltas, making it impossible to assess near-term growth expectations. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the lack of going-concern language in source documents. No dilution risk is currently identified, as the diluted share count is equal to the basic share count. Recent events, such as filings or transcripts, are not disclosed in the available data. Without access to 10-K, 10-Q, or earnings call transcripts, it is not possible to evaluate recent strategic or operational developments.

30-day price · ACU-2.82 (-6.3%)
Low$39.31High$47.14Close$41.69As of19 May, 00:00 UTC
Profile
CompanyAcme Pesticides Ltd
TickerACME.DH
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Acme Pesticides Ltd develops, produces, and distributes agricultural chemicals, primarily targeting crop protection and pest control markets.

Classification. Acme Pesticides Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry with 92% confidence.

Acme Pesticides Ltd has a fully diluted share count of 135 million, with no difference between basic and diluted shares, indicating no dilution risk from stock options or convertible instruments. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available for comparison against industry medians, as no financial data is provided in the valuation snapshot. In the Agricultural Chemicals industry, key metrics such as EBITDA margins, ROIC, and net profit margins are typically used to assess performance. Without these, a direct comparison to industry benchmarks is not possible. The company's revenue concentration by segment and geography is not disclosed in the available data. In the absence of segmental or geographic breakdowns, it is unclear whether Acme Pesticides Ltd is exposed to regional or product-specific concentration risks. Disclosed segments would typically include crop protection, industrial chemicals, or specialty products, but none are available for analysis. Growth trajectory data is also unavailable, as no revenue history or outlook figures are provided. The outlook section does not include current or next fiscal year direction or numeric deltas, making it impossible to assess near-term growth expectations. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the lack of going-concern language in source documents. No dilution risk is currently identified, as the diluted share count is equal to the basic share count. Recent events, such as filings or transcripts, are not disclosed in the available data. Without access to 10-K, 10-Q, or earnings call transcripts, it is not possible to evaluate recent strategic or operational developments.
Key takeaways
  • Acme Pesticides Ltd has no dilution risk based on current share counts.
  • Liquidity risk could not be assessed due to missing balance-sheet data.
  • No profitability metrics are available for comparison to industry benchmarks.
  • Revenue concentration by segment or geography is not disclosed.
  • Growth trajectory and outlook data are unavailable.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4
FY-3
FY-2
FY-1
FY0
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4
FY-3
FY-2
FY-1
FY0
PeriodOCFCapExFCFSBC
FY-4
FY-3
FY-2
FY-1
FY0
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricACMEActivity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity37.1% medp25 10.3% · p75 82.0%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 03:22 UTC#96eee699
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 06:21 UTCJob: ce8ec5c7